2013
Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia
Young LH, Henderson KJ, White RI, Garcia‐Tsao G. Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia. Hepatology 2013, 58: 442-445. PMID: 23686865, DOI: 10.1002/hep.26472.Commentaries, Editorials and Letters
2011
Congenital Hepatic Vascular Malformations
Garcia-Tsao G. Congenital Hepatic Vascular Malformations. 2011, 213-227. DOI: 10.1007/978-1-4419-8327-5_14.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements